Output details

FIXATOR

Our previous interdisciplinary research demonstrated that promotion of callus is obtained by allowing dynamisation (the interfragmentary movement that occurs during loading and unloading of the fracture) of specific forms. We also demonstrated that fracture healing could be assessed using manipulation and measurement. However, the research that led to this output was to achieve said dynamisation and measurement with no moving parts and no electronics. The patent presents a solution that resolves this issue of practicality. To achieve this outcome we needed to conduct fundamental research that allowed us to design a single piece body that produces a specified motion under normal, human ambulation. We also needed to ensure that this embodiment contained the passive fracture healing methodology proposed by our fundamental research. During this research output MOORCROFT (3) was produced. Furthermore MOORCROFT (4) is another aspect that was a result of this research.

Our current research demonstrates that we have achieved this with reduced healing times (from some 16-18 weeks to 9 weeks); also the fracture assessment method has been confirmed. This patent is granted (PCT) and exploited. Presently the device is limited to key opinion leaders but has both CE marking and FDA clearance to market (entailing commercial clinical research to fulfil their requirements). It is due for general release in early 2014. It has been granted by the UK, EU and US patent offices and hence as undergone external review by these bodies.